Alantra advises Univet’s shareholders on the acquisition of Okivet

Jan 2026

Buy-side advisory

Paris – Alantra has acted as buy-side advisor to Univet’s shareholders, including InfraVia Capital Partners and management, on Univet’s acquisition of Okivet, a French veterinary clinic network.

Univet is one of France’s leading veterinary clinic groups, with a presence across France and Belgium. Backed by InfraVia, the group has pursued an active buy-and-build strategy focused on expanding its position in companion animal care while preserving practitioners’ medical independence through a centralized services platform.

Founded in 2020 by Dr. Fabrice Crépin, Okivet has developed through the acquisition and integration of independent veterinary practices. The network comprises 27 clinics and approximately 150 employees, further strengthening Univet’s footprint in the French veterinary services market.

Alantra supported Univet’s shareholders throughout the transaction, providing senior-level advice in a founder-led process. The transaction drew on Alantra’s relationship-led execution approach, healthcare services expertise, and ability to support strategic buy-side discussions in consolidation-driven markets.

Franck Noat, Managing Partner at Alantra, said:  “Okivet is a strategic addition to Univet’s French platform, strengthening its clinic network while remaining aligned with its practitioner-led model. We were pleased to support InfraVia and the management team through a founder-led process where sector knowledge, senior dialogue, and execution certainty were key to achieving a successful outcome.”

This transaction reinforces Alantra’s activity across animal health and adjacent pet care markets in France, following its recent role as exclusive debt advisor to Nasta Pet Food on a €120mn unitranche financing supporting its acquisition of FirstMate Pet Foods.